Treatment Action Group

Good COPs or Bad COPs webinar: Promoting interventions for co-infections and AIDS in 2020 PEPFAR COPs

Treatment Action Group, Médecins Sans Frontières and Health GAP will host a webinar on 22 January 2020 on how to engage in PEPFAR Country Operational Plans (COPs) advocacy and promote the prioritization of interventions that address HIV co-infections and AIDS.

Read More →

New TAG report: Funding for TB research climbed to new high in 2018

The report — Tuberculosis Research Funding Trends, 2005–2018 — presents new data on funding for TB research and development in 2018 and analyzes trends in spending since 2005.

Read More →

TAG applauds Indian TB activists in opposing patents for critical TB prevention drugs

Civil society takes legal action to contest patent applications filed by Sanofi on fixed-dose combinations of two decades-old drugs used to prevent TB.

Read More →

TAG’s 2019 Pipeline Report: Three TB sections released

The sections provide an overview of TB diagnostics, vaccines and treatment.

Read More →

Public investments in TB medicine bedaquiline far exceed those of developer Johnson & Johnson

Quantification of investments in the development of bedaquiline finds total public and philanthropic expenditures are three to five times those of Johnson & Johnson.

Read More →

Protestors demand Cepheid halve the price of GeneXpert TB tests to US$5

The high cost of GeneXpert tests for TB leaves open a critical gap in the diagnosis of TB and fails to consider volume of sales and public investments in the development of GeneXpert.

Read More →

TAG welcomes unprecedented U.S. support for TB research, urges all countries to increase investments

TAG welcomes the news of increased investment from the U.S. government in TB research and development; urges all countries to follow through on commitments made at the 2018 UN High-Level Meeting on TB.

Read More →

Practice-based recommendations for the management of RR/MDR-TB

Statement from DR-TB STAT and TAG outlining practice-based recommendations for the optimal management of RR/MDR-TB. 

Read More →

TAG’s 2019 Pipeline Report: Pediatric TB section released

The section provides an overview of research and development of innovations for diagnosing, preventing, treating TB in children.

Read More →

Crisis of confidence in the WHO's ability to produce normative guidance for the treatment of RR-/MDR-TB

Advocates request an urgent in-person meeting with the WHO leadership to discuss concrete actions to address technical and guideline development process-related issues previously raised.

Read More →

Page 2 of 15 · Total posts: 10

←First 1 2 3 Last→